Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna(®)) with the human ABC drug transporter P-glycoprotein

Схожие документы

• Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna® (Nilotinib): Evidence for transport of Tasigna® and its fluorescent derivative by ABC drug transporters
  по: Shukla, Suneet, et al.
  Опубликовано: (2011)
• Pharmacophore Modeling of Nilotinib as an Inhibitor of ATP-Binding Cassette Drug Transporters and BCR-ABL Kinase Using a Three-Dimensional Quantitative Structure–Activity Relationship Approach
  по: Shukla, Suneet, et al.
  Опубликовано: (2014)
• Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors
  по: Duveau, Damien Y., et al.
  Опубликовано: (2012)
• Use of Baculovirus BacMam Vectors for Expression of ABC Drug Transporters in Mammalian Cells
  по: Shukla, Suneet, et al.
  Опубликовано: (2012)
• Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1)
  по: Chufan, Eduardo E., et al.
  Опубликовано: (2013)